1. Home
  2. ADMA vs CYTK Comparison

ADMA vs CYTK Comparison

Compare ADMA & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • CYTK
  • Stock Information
  • Founded
  • ADMA 2004
  • CYTK 1997
  • Country
  • ADMA United States
  • CYTK United States
  • Employees
  • ADMA N/A
  • CYTK N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADMA Health Care
  • CYTK Health Care
  • Exchange
  • ADMA Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • ADMA 5.1B
  • CYTK 5.6B
  • IPO Year
  • ADMA N/A
  • CYTK 2004
  • Fundamental
  • Price
  • ADMA $17.74
  • CYTK $32.43
  • Analyst Decision
  • ADMA Strong Buy
  • CYTK Buy
  • Analyst Count
  • ADMA 4
  • CYTK 14
  • Target Price
  • ADMA $24.25
  • CYTK $70.92
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • CYTK 1.3M
  • Earning Date
  • ADMA 08-07-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • ADMA N/A
  • CYTK N/A
  • EPS Growth
  • ADMA N/A
  • CYTK N/A
  • EPS
  • ADMA 0.84
  • CYTK N/A
  • Revenue
  • ADMA $459,381,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • ADMA $23.35
  • CYTK $18.02
  • Revenue Next Year
  • ADMA $27.67
  • CYTK $737.32
  • P/E Ratio
  • ADMA $21.27
  • CYTK N/A
  • Revenue Growth
  • ADMA 62.23
  • CYTK 412.21
  • 52 Week Low
  • ADMA $10.21
  • CYTK $29.31
  • 52 Week High
  • ADMA $25.67
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 32.83
  • CYTK 46.32
  • Support Level
  • ADMA $20.42
  • CYTK $32.02
  • Resistance Level
  • ADMA $22.37
  • CYTK $34.72
  • Average True Range (ATR)
  • ADMA 0.88
  • CYTK 1.30
  • MACD
  • ADMA -0.28
  • CYTK 0.26
  • Stochastic Oscillator
  • ADMA 1.07
  • CYTK 45.08

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: